There is evidence that relative corticosteroids anti-inflammatory resistance in COPD may be partly due to decrease in histone deacetylase activity, and especially the type-2 enzyme (HDAC2) [6], [7]. This evidence concerns the gene HDAC2 and chronic obstructive pulmonary disease.